PT  - JOURNAL ARTICLE
AU  - Brownstein, Naomi C
AU  - Chen, Yian Ann
TI  - Predictive values, uncertainty, and interpretation of serology tests for the novel coronavirus
AID  - 10.1101/2020.06.04.20122358
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.06.04.20122358
4099  - http://medrxiv.org/content/early/2020/12/15/2020.06.04.20122358.short
4100  - http://medrxiv.org/content/early/2020/12/15/2020.06.04.20122358.full
AB  - Antibodies testing in the coronavirus era is frequently promoted, but the underlying statistics behind their validation has come under more scrutiny in recent weeks. We provide calculations, interpretations, and plots of positive and negative predictive values under a variety of scenarios. Prevalence, sensitivity, and specificity are estimated within ranges of values from researchers and antibodies manufacturers. Illustrative examples are highlighted, and interactive plots are provided in the Supplementary Material. Implications are discussed for society overall and across diverse locations with different levels of disease burden. Specifically, the proportion of positive serology tests that are false can differ drastically from up to 3% to 88% for people from different places with different proportions of infected people in the populations while the false negative rate is typically under 10%.Competing Interest StatementDr. Brownstein (NCB) served as an ad-hoc reviewer in 2020 for the American Cancer Society, for which she received sponsored travel during the review meeting and a stipend of $300. NCB received a series of small awards for conference and travel support, including $500 from the Statistical Consulting Section of the American Statistical Association for Best Paper Award at the 2019 Joint Statistical Meetings and the $500 Lee Travel Award from the Caucus for Women in Statistics to support attendance at the 2018 Joint Statistical Meetings. NCB also received a Michael Kutner/ASA Junior Faculty Travel Award of $946.60 to attend the 2018 Summer Research Conference of the Southern Regional Council on Statistics and travel support of $708.51 plus a registration waiver from the American Statistical Association (ASA) to attend and chair a session for the 2017 Symposium on Statistical Inference. Both authors (NCB and YAC) were supported by the the National Cancer Institute (5P30 CA076292-22) and the Biostatistics and Bioinformatics Core at the H. Lee Moffitt Cancer Center & Research. NCB serves as the Florida Chapter Representative for the ASA and as the mentoring subcommittee chair for the Regional Advisory Board (RAB) of the Eastern North American Region (ENAR) of the International Biometrics Society (IBS). She was also recently elected as Section Representative for the ASA Statistical Consulting Section for 2021-2023. YAC is a member of the International Society for Computational Biology and American Association for Cancer Research. Both authors are members of the ASA and serve on the SRC at Moffitt Cancer Center.Funding StatementThe authors were supported by a grant from the National Cancer Institute (5P30 CA076292-22) and by the Biostatistics and Bioinformatics Core at the H. Lee Moffitt Cancer Center & Research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB oversight was required for this secondary statistical analysis with no data from human subjects.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData and code utilized for this paper are available in our github repository at https://github.com/nbrownst/AntibodiesPredictiveValues. https://github.com/nbrownst/AntibodiesPredictiveValues